Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2024

Institutional positions in Recursion Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
248
+50 vs. Q4 2023
Shares held
212.9M
+6.36M (+3.1%) vs. Q4 2023
Total value
$2.12B
+$85.3M (+4.2%) vs. Q4 2023
New holders
69
88 more added
Sold out
19
53 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 248 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ1 2024: $2.12B
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q4 2023.

Institutions holding RXRX in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Sculptor Capital LP318,400$3.17M0.07%+318,400New
Citadel Advisors LLC340,374$3.39M0.00%+303,880+832.7%Added
First Trust Advisors LP377,725$3.77M0.00%+125,032+49.5%Added
Marshall Wace, LLP391,518$3.90M0.01%+391,518New
Principal Financial Group Inc397,654$3.96M0.00%−285,954−41.8%Reduced
Ensign Peak Advisors, Inc398,936$3.98M0.01%+11,421+2.9%Added
Point72 Asset Management, L.P.400,700$3.99M0.01%−1,069,500−72.7%Reduced
Bellevue Group AG425,249$4.24M0.06%+250,692+143.6%Added
Institute for Wealth Management, LLC.581,149$5.79M0.75%+581,149New
Voloridge Investment Management, LLC660,969$6.59M0.02%+76,014+13.0%Added
UBS Group AG672,431$6.70M0.00%−19,480−2.8%Reduced
Cercano Management LLC685,018$6.83M0.19%00.0%Unchanged
Liontrust Investment Partners LLP750,000$7.48M0.10%+235,000+45.6%Added
Nuveen Asset Management, LLC796,902$7.95M0.00%+239,999+43.1%Added
Citigroup Inc801,187$7.99M0.01%+396,334+97.9%Added
Susquehanna International Group, LLP833,872$8.31M0.01%+469,674+129.0%Added
Bank of New York Mellon Corp881,810$8.79M0.00%+48,535+5.8%Added
Rafferty Asset Management, LLC890,239$8.88M0.03%−199,934−18.3%Reduced
Two Sigma Investments, LP896,480$8.94M0.02%+363,840+68.3%Added
Goldman Sachs Group Inc897,020$8.94M0.00%−294,785−24.7%Reduced
Vestmark Advisory Solutions, Inc.900,019$8.97M0.39%+427,763+90.6%Added
Laurion Capital Management LP907,616$9.05M0.25%00.0%Unchanged
Comprehensive Financial Management LLC941,895$9.39M0.30%00.0%Unchanged
JPMorgan Chase & Co1,082,105$10.8M0.00%+701,295+184.2%Added
Charles Schwab Investment Management Inc1,213,012$12.1M0.00%+22,130+1.9%Added
Northern Trust Corp1,286,690$12.8M0.00%−8,897−0.7%Reduced
Bank of America Corp1,702,914$17.0M0.00%+917,637+116.9%Added
Platinum Investment Management Ltd1,800,469$18.0M0.72%−473,495−20.8%Reduced
Credit Suisse AG1,936,970$19.3M0.02%+234,914+13.8%Added
Morgan Stanley1,963,777$19.6M0.00%−612,122−23.8%Reduced
Dimensional Fund Advisors LP2,095,000$20.9M0.01%−42,110−2.0%Reduced
Exor Capital LLP2,175,077$21.7M0.91%+300,000+16.0%Added
Norges Bank3,172,542$31.6M0.00%−359,422−10.2%Reduced
Geode Capital Management, LLC3,451,165$34.4M0.00%+125,180+3.8%Added
DCVC Opportunity Fund II GP, LLC3,951,141$39.4M55.14%00.0%Unchanged
Data Collective IV GP, LLC5,941,120$59.2M51.36%00.0%Unchanged
NVIDIA Corp7,706,363$76.8M23.09%00.0%Unchanged
MIC Capital Management UK LLP8,451,758$84.3M16.00%00.0%Unchanged
FMR LLC9,260,871$92.3M0.01%−1,636,416−15.0%Reduced
Nikko Asset Management Americas, Inc.10,362,803$103.1M1.02%+1,159,023+12.6%Added
State Street Corp10,352,356$103.2M0.00%−1,799,290−14.8%Reduced
Sumitomo Mitsui Trust Holdings, Inc.10,362,803$103.3M0.07%+1,159,023+12.6%Added
Kinnevik AB (publ)10,405,668$103.7M100.00%00.0%Unchanged
BlackRock Inc.12,321,035$122.8M0.00%−72,837−0.6%Reduced
Mubadala Investment Co PJSC12,985,927$129.5M0.51%00.0%Unchanged
Vanguard Group Inc16,014,764$159.7M0.00%+349,554+2.2%Added
Baillie Gifford & Co24,067,804$240.0M0.19%−111,700−0.5%Reduced
ARK Investment Management LLCSuperinvestorARK Invest24,587,561$245.1M1.70%+3,933,274+19.0%Added
Duquesne Family Office LLCSuperinvestorDuquesne Family Office0$00.00%−906,767−100.0%Sold out
Captrust Financial Advisors0$00.00%−419,721−100.0%Sold out
CIBC Private Wealth Group, LLC0$00.00%−136,753−100.0%Sold out
Pentwater Capital Management LP0$00.00%−100,000−100.0%Sold out
Cetera Advisor Networks LLC0$00.00%−36,628−100.0%Sold out
FDx Advisors, Inc.0$00.00%−23,299−100.0%Sold out
SG Americas Securities, LLC0$00.00%−22,186−100.0%Sold out
GoalFusion Wealth Management, LLC0$00.00%−20,000−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−19,733−100.0%Sold out
XTX Topco Ltd0$00.00%−15,349−100.0%Sold out
Gladstone Institutional Advisory LLC0$00.00%−13,492−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−10,860−100.0%Sold out
E. Ohman J:or Asset Management AB0$00.00%−7,482−100.0%Sold out
Itau Unibanco Holding S.A.0$00.00%−3,161−100.0%Sold out
Tradition Wealth Management, LLC0$00.00%−1,584−100.0%Sold out
O'Dell Group, LLC0$00.00%−1,200−100.0%Sold out
Advisory Services Network, LLC0$00.00%−1,110−100.0%Sold out
New Millennium Group LLC0$00.00%−275−100.0%Sold out
American Capital Advisory, LLC0$00.00%−200−100.0%Sold out
Coppell Advisory Solutions LLC––––Not filed